Clinical Trial Search

Primary: Feasibility of the Use of Antibiotic Solution Instillation Following Intraoperative Diagnosis of Complex Appendicitis as Assessed by Percentage of Eligible Participants…

Primary: Number of Emergency Department Visits or Hospital Admissions — 0.33; 0.35 events per 100 person-days alive

Primary: Change in Morphine Milligram Equivalent (MME) Average Daily Dose — 8; 4; 5; 5 participants — p=>.05

Primary: Change in Adherence to Mediterranean Diet (aMed) Score. The Change Was Calculated From Two Time Points as the Value at the Later Time Point Minus the Value at the…

Primary: Percentage of Participants With a Scalp-specific Physician Global Assessment Score of 0 or 1 (Ss-PGA 0/1) at Week 16 — 48.5; 13.7; 50.0; 12.8 Percentage of responders…

Primary: Area of Dermatomal Sensory Loss at 20 Min — 68.8; 167.5 cm^2

Primary: Treatment Completion Rate. — 294; 248; 250 Participants

Primary: Change From Baseline in Reflux Disease Questionnaire (RDQ) Scores for the GERD Dimension — -1.27; -1.06 score on a scale — p=<0.0001

Primary: Systemic Vancomycin Level - Start of Case — 27.98; 0 ug/mL

Primary: Change From Baseline in Mean Dysphagia Days (DD) at Week 24 — -6.85; -4.98 days — p=0.0005

Primary: The Number of Participants Who Have Completed >90% of Their Recommended Cytomegalovirus (CMV) Monitoring Tests in the DBS and Control Arms in the ITT Population — 27; 15…

Primary: Percent Change in LDL-C From Baseline to Week 12 — -25.25; -3.46 Percent Change — p=0.001

Primary: Percentage of Participants With Chronic ITP With a Sustained Platelet Count Response Defined as Achieving Platelet Counts of at Least 50×10^9/L for at Least 4 of the 6…

Primary: Incidence of Preterm (<37 Weeks) Preeclampsia — 22; 16 Participants — p=0.28

Primary: Change in 10-Meter Walk Test (Interventional) — 0.18; -0.05 meters/second